jenrindiscovery.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | Jenrin |
| Description | Jenrin Discovery is a privately-held, company focused on discovery and development of small molecule product candidates designed to target peripheral |
| Keywords | Jenrin Discovery, John McElroy, discovery, drug, development, Delaware, molecule, obesity |
Server Information
| WebSite | |
| Host IP | 162.241.217.81 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
jenrindiscovery.com Valuation
|
US$939,530
Last updated: 2023-05-15 08:10:30
jenrindiscovery.com has Semrush global rank of 11,265,537. jenrindiscovery.com has an estimated worth of US$ 939,530, based on its estimated Ads revenue. jenrindiscovery.com receives approximately 108,408 unique visitors each day. Its web server is located in United States, with IP address 162.241.217.81. According to SiteAdvisor, jenrindiscovery.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$939,530 |
| Daily Ads Revenue | US$868 |
| Monthly Ads Revenue | US$26,018 |
| Yearly Ads Revenue | US$312,213 |
| Daily Unique Visitors | 7,228 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| jenrindiscovery.com. | A | 7199 | IP: 162.241.217.81 |
| jenrindiscovery.com. | NS | 86400 | NS Record: ns1.bluehost.com. |
| jenrindiscovery.com. | NS | 86400 | NS Record: ns2.bluehost.com. |
| jenrindiscovery.com. | MX | 14400 | MX Record: 0 jenrindiscovery-com.mail.protection.outlook.com. |
| jenrindiscovery.com. | TXT | 14400 | TXT Record: v=spf1 include:spf.messagelabs.com include:mxlogic.net jenrindiscovery.com ~all |
HtmlToTextCheckTime:2023-05-15 08:10:30
| Jenrin Discovery Home About Us leadership board of directors investors Pipeline Development Status PS CB1 Program News & Information Contact us Jenrin licenses lead compound, JD5037, and library targeting the CB1 receptor to Corbus Pharmaceuticals Jenrin Discovery is a privately-held pharmaceutical company developing a pipeline of proprietary ‘first-in-class’ small molecule drugs designed to selectively target peripheral tissues. Many marketed drugs, with efficacy not dependent on brain penetration are plagued by a sub-optimal safety profile, due to accompanying psychiatric and neurologic side effects. Jenrin has applied its medicinal chemistry expertise to structurally modify such agents so as to prevent penetration across the blood-brain barrier, resulting in negligible or no brain levels of compound. The new peripherally restrictive (PR) chemical entities retain the pharmacological activity and many of the drug properties of the parent therapeutic with little or no risk of the |
HTTP Headers
HTTP/1.1 200 OK Date: Mon, 27 Dec 2021 08:21:37 GMT Server: Apache Upgrade: h2,h2c Connection: Upgrade Last-Modified: Thu, 23 May 2019 04:30:39 GMT Accept-Ranges: bytes Content-Length: 18471 Vary: Accept-Encoding host-header: c2hhcmVkLmJsdWVob3N0LmNvbQ== Content-Type: text/html |
jenrindiscovery.com Whois Information
Domain Name: JENRINDISCOVERY.COM Registry Domain ID: 153194122_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.enom.com Registrar URL: http://www.enomdomains.com Updated Date: 2017-08-08T21:27:06Z Creation Date: 2005-04-27T19:00:12Z Registry Expiry Date: 2022-04-27T19:00:12Z Registrar: eNom, LLC Registrar IANA ID: 48 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS1.BLUEHOST.COM Name Server: NS2.BLUEHOST.COM DNSSEC: unsigned >>> Last update of whois database: 2021-12-29T07:51:36Z <<< |